Abstract:Red blood cell (RBC) transfusion has become one of the most commonly utilized life-saving therapies in medicine with approximately 12–16 million units transfused in the US per year [1,2]. Since storage solutions were developed 100 years ago, they have been modified to allow for increased storage duration, primarily to increase availability, especially in remote areas, such as during combat operations [3]. Currently in the US and Europe, RBCs can be stored up to 42–56 days based upon at least 75% of radiochromium-labeled cells remaining in the circulation at 24 h after infusion and hemolysis less than 1% [4,5]. As RBCs are stored over time, the metabolic and biochemical changes that occur have been coined ‘the storage lesion.’ To further improve the availability of RBCs, it is standard for blood distributors to transfer RBCs that are close to expiration at community hospitals to medical centers where utilization rates are higher, and for hospital blood banks to issue the ‘first-in, first-out’ inventory to reduce RBC outdating and waste [2,6]. A consequence of these policies focused on inventory management is that patients with increased severity of illness are transfused RBCs of increased storage duration compared to less acutely ill patients. It is important to recognize that as storage duration for RBC units has increased for logistical purposes, there has not been a commensurate evaluation of clinical efficacy or safety. As a result of the preferential allocation of older RBCs to sicker patients, there has been concern regarding the quality of RBCs after prolonged storage related to both efficacy and safety. This has led to a significant amount of research into the clinical relevance of the storage lesion with laboratory, preclinical, and clinical studies [4,7–9]. The results of these studies suggested biologic plausibility that the RBC storage lesion was potentially able to affect outcomes, especially in critically ill populations. These studies though are limited due to potential bias and higher-quality studies were needed to more accurately determine if RBC storage age affects outcomes. Consequently, a few randomized controlled trials (RCTs) have been completed, and a few are still underway. Dissecting out what each of these studies may mean for patients who are transfused RBCs based upon the population studied and their design is controversial. 2. ‘Storage lesion’

Breast cancer: overview of current management considerations of economic impact. Based on a presentation by Sandra E. Brooks, MD, FACS, FACOG.

Rapid On-Site Detection of Illicit Drugs in Smuggled Samples with a Portable Electrochemical Device

Integrated Sensing Platform Validated for the Efficient and On-Site Screening of Amine-Containing Illicit Drugs

The annual cycle in luteinizing hormone in the plasma of intact and castrated white-crowned sparrows, Zonotrichia leucophrys gambelii.

Thoracoscopic mobilization of the esophagus

Real-time electrochemical screening of cocaine in lab and field settings with automatic result generation

On-site illicit-drug detection with an integrated near-infrared spectral sensor: A proof of concept

Rapid and On-Site Analysis of Illegal Drugs on the Nano-Microscale Using a Deep Ultraviolet-Visible Reflected Optical Fiber Sensor.

Spatial Dissemination of Some Heavy Metals in Soil Adjacent to Bhaluka Industrial Area, Mymensingh, Bangladesh

Real time detection of amphetamine in oral fluids by MicroNIR/Chemometrics

Component deficiencies. 6. The sixth component.

Disposable microfluidic device with ultraviolet detection for highly resolved screening of illicit drugs.

Rapid Duplexed Detection of Illicit Drugs in Wastewater Using Gold Nanoparticle Conjugated Aptamer Sensors

End‐Tidal and Arterial Gas Tension Levels in Postanesthetic Respiratory Depression

Integrated Aptasensor Array for Sweat Drug Analysis

Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.

Non-contact identification and differentiation of illicit drugs using fluorescent films

Rapid On-Site Detection of Illicit Drugs in Urine Using C18 Pipette-Tip Based Solid-Phase Extraction Coupled with a Miniaturized Mass Spectrometer

A handheld fluorescent lateral flow immunoassay platform for highly sensitive point-of-care detection of methamphetamine and tramadol

Red blood cell storage age – what we know from clinical trials

A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints